PM287. Mixtures of opioid receptor agonists and cannabinoid receptor agonists: enhanced antinociception without abuse liability

Antzeko izenburuak

• Additive antinociceptive effects of mixtures of the kappa opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats
  nork: Maguire, David R., et al.
  Argitaratua: (2016)
• Antinociceptive effects of mixtures of mu opioid receptor agonists and cannabinoid receptor agonists in rats: impact of drug and fixed-dose ratio
  nork: Maguire, David R., et al.
  Argitaratua: (2017)
• Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats
  nork: Minervini, Vanessa, et al.
  Argitaratua: (2017)
• Impact of Efficacy at the μ-Opioid Receptor on Antinociceptive Effects of Combinations of μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists
  nork: Maguire, David R., et al.
  Argitaratua: (2014)
• Interactions between μ-Opioid Receptor Agonists and Cannabinoid Receptor Agonists in Rhesus Monkeys: Antinociception, Drug Discrimination, and Drug Self-Administration
  nork: Maguire, David R., et al.
  Argitaratua: (2013)